Home Latest FA news Abstract - A TAT-Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich’s Ataxia mouse model

Abstract - A TAT-Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich’s Ataxia mouse model

User Rating: / 1
PoorBest 
ShareShare

Dr. Mark PayneDr. Mark PayneKindly supplied by Juan Carlos Baiges through the FAPG mailing-list


Accepted November 21, 2011.

Abstract

Friedreich’s Ataxia (FRDA) is the most common inherited human ataxia and results from a deficiency of the mitochondrial protein, frataxin, which is encoded in the nucleus. This deficiency is associated with an iron-sulfur (Fe-S) cluster enzyme deficit leading to progressive ataxia and a frequently fatal cardiomyopathy. There is no cure. To determine if exogenous replacement of the missing frataxin protein in mitochondria would repair the defect, we used the TAT protein transduction domain to deliver human frataxin protein to mitochondria in both cultured patient cells and a severe mouse model of Friedreich’s Ataxia. A TAT-Frataxin (TAT-FXN) fusion protein bound iron in vitro, transduced into mitochondria of FRDA deficient fibroblasts, and reduced caspase 3 activation in response to an exogenous iron oxidant stress.

Injection of TAT-FXN protein into mice with a conditional loss of frataxin increased their growth velocity and mean lifespan by 53%, increased their mean heart rate and cardiac output, increased activity of aconitase, and reversed abnormal mitochondrial proliferation and ultrastructure in heart. These results show that a cell penetrant peptide is capable of delivering a functional mitochondrial protein in vivo to rescue a very severe disease phenotype, and present the possibility of TAT-Frataxin as a protein replacement therapy.

Source: Human molecular Genetics

°°°°°°°°°°°°

Piyush M. Vyas1, Wendy J. Tomamichel1, P. Melanie Pride1, Clifford M. Babbey1, Qiujuan Wang1, Jennifer Mercier2, Elizabeth M. Martin1 and R. Mark Payne1,*
+ Author Affiliations
1Riley Heart Research Center, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, 46202
2Wake Forest University School of Medicine, Winston-Salem, NC, 27157
?*Corresponding Author: R. Mark Payne, Riley Hospital for Children, Wells Center for Pediatric Research, 1044 West Walnut, R4366, Indianapolis, IN 46202, O: 317-278-6239, FAX: 317-278-9298; Email: rpayneATiupui.edu

 

Comments
Search
Only registered users can write comments!

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Last Updated on Saturday, 31 March 2012 11:24  

BabelTravels

- Raise funds for biomedical research for Friedreich's ataxia

- Get in touch with other people in the ataxia community

- Travel to other countries

How can you do all three at the same time? BABELTRAVELS is the answer. Click here to find out more! 

 

 

Our channels

Login Form

Recent videos

Polls

What kind of content are you most interested in?
 

Search

Visitors' map (last day)

Loading map...

Time (GMT -5) Country City Search Phrase Referrer

Download "The Castle of Albanza"

Download 'The Castle of Albanza', María Blasco's latest novel, for just 10 USD, by clicking on the image above. You will be redirected to the file after the payment process. All funds raised will be destined to Friedreich's Ataxia research. For any questions, please contact: coordination@babelfamily.org

Research projects funded by BabelFAmily

These are the research projects we are currently funding or co-funding:

Professor Pierre Rustin's research project (Robert Debré Hospital, Paris) (2010-2012). More information

Professor Michele Lufino's research project (Oxford University, 2011-2012). More information